Internal Medicine, Medical Oncology · Houston, TX
NPI
1467401224
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
11920 Astoria Blvd Ste 240
Houston, TX, 77089
Phone (832) 932-1730
Groups this clinician bills Medicare through
Medicare paid, 2024
$778K
64,033 services
Medicare patients, 2024
183
Average age 75
Drug cost, 2024
$4.4M
1,539 prescriptions
Company payments, 2025
$832
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nadya Hasham-Jiwa was code 99214 (office e&m - established), 363 times for 140 patients. In total Nadya Hasham-Jiwa billed 64,033 services in 84 codes, and Medicare paid $778K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 363 | 140 | $89.87 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 184 | 119 | $12.83 | $2,361 |
| 96372 Injection Administration | Office | 161 | 23 | $10.60 | $1,707 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 104 | 11 | $4.57 | $475 |
| 99213 Office E&M - Established | Office | 91 | 64 | $64.26 | $5,848 |
| 96413 Chemotherapy Administration | Office | 87 | 15 | $99.66 | $8,671 |
| 96365 Intravenous Infusion, Hydration | Office | 66 | 24 | $45.09 | $2,976 |
| 99215 Office E&M - Established | Office | 52 | 36 | $136.95 | $7,121 |
| 99205 Office E&M - New | Office | 21 | 21 | $173.74 | $3,649 |
| 99204 Office E&M - New | Office | 19 | 19 | $119.86 | $2,277 |
By year: 2022 $1.3M for 72,013 services; 2023 $889K for 72,778 services; 2024 $778K for 64,033 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 26 | 17 | $2.95 | $76.71 |
Medicare prescription drug claims, 2024
In 2024, the drug Nadya Hasham-Jiwa prescribed most often to Medicare patients was Anastrozole, with 338 prescriptions and refills. In total Nadya Hasham-Jiwa wrote 1,539 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 338 | 933 | 98 | $5,828 |
| Letrozole Generic | 136 | 353 | 47 | $3,553 |
| Verzenio Abemaciclib | 73 | 73 | Under 11 | $1.1M |
| Xarelto Rivaroxaban | 46 | 71 | Under 11 | $38K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 43 | 53 | Under 11 | $157 |
| Imbruvica Ibrutinib | 41 | 43 | Under 11 | $399K |
| Dexamethasone Generic | 39 | 41 | 24 | $768 |
| Eliquis Apixaban | 39 | 56 | Under 11 | $33K |
| Ondansetron Odt Ondansetron | 38 | 38 | 34 | $777 |
| Famciclovir Generic | 34 | 48 | Under 11 | $1,599 |
| Gabapentin Generic | 33 | 37 | Under 11 | $260 |
| Exemestane Generic | 32 | 76 | Under 11 | $6,128 |
| Loperamide Loperamide Hcl | 31 | 31 | 23 | $373 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 31 | 31 | 30 | $318 |
| Granisetron Hcl Generic | 24 | 24 | 22 | $6,294 |
Brand drugs: 381 claims; generic drugs: 1,158 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nadya Hasham-Jiwa $832 ($832 in general payments such as food, travel and fees) from 17 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $163.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $163 |
| Merck Sharp & Dohme LLC MRK | 4 | $94.46 |
| Pfizer Inc. PFE | 3 | $92.04 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $81.79 |
| Astellas Pharma US Inc 4503.T | 4 | $63.63 |
| Genzyme Corporation SNY | 1 | $39.74 |
| SpringWorks Therapeutics, Inc. | 1 | $37.39 |
| Gilead Sciences, Inc. GILD | 2 | $36.55 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $32.77 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $31.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.